Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.02K Hold
119
﹤0.01% 713
2026
Q1
$7.47K Hold
119
﹤0.01% 701
2025
Q4
$7.9K Hold
119
﹤0.01% 694
2025
Q3
$8.01K Sell
119
-1,781
-94% -$141K ﹤0.01% 673
2025
Q2
$166K Buy
1,900
+1,781
+1,497% +$140K 0.01% 312
2025
Q1
$8.13K Hold
119
﹤0.01% 585
2024
Q4
$9.26K Sell
119
-8
-6% -$592 ﹤0.01% 591
2024
Q3
$8.51K Hold
127
﹤0.01% 562
2024
Q2
$14.4K Hold
127
﹤0.01% 503
2024
Q1
$17.6K Hold
127
﹤0.01% 499
2023
Q4
$15.8K Buy
127
+119
+1,488% +$12.2K ﹤0.01% 513
2023
Q3
$746 Hold
8
﹤0.01% 702
2023
Q2
$1.03K Buy
+8
New +$968 ﹤0.01% 673

Other funds holding DXCM

D.J. St. Germain's DXCM Position: Q2 2026 in Review

D.J. St. Germain held its DexCom (DXCM) position steady in Q2 2026 at 119 shares worth $8.02K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

D.J. St. Germain first reported a position in DXCM in Q2 2023 and has held it in 13 quarters since. The position peaked at $166K in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • D.J. St. Germain held 119 shares of DexCom worth $8.02K as of Q2 2026.
  • D.J. St. Germain left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #713 holding.
  • D.J. St. Germain first reported a position in DexCom in Q2 2023 and has held it in 13 quarters since.
  • D.J. St. Germain's DexCom position peaked at $166K in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.